step 9 semaglutide versus placebo in individuals with poor weight loss after bariatric surgery: a double-blinded, randomized, placebo-controlled trial Effect of semaglutide 2.4 mg

Initially, it was used to treat diabetes, and then it was approved by the FDA for weight loss treatment and is administered as a once-weekly injection

Semaglutide, however, was given in daily doses of 0.05mg, 0.1mg, 0.2mg, 0.3mg or 0.4mg

en EE UU, donde los medicamentos suelen ser ms caros, ha llegado a costar 1 349 dlares al mes

When a doctor may suggest other options A clinician may recommend different treatments if someone: Has a very high BMI and might benefit more from a surgical option Has a health condition that makes GLP-1 treatment unsafe Cannot continue because of ongoing side effects Has used semaglutide before without the expected results In these cases, the aim is to choose another safe and proven approach